Company Albany Molecular Research, Inc.
Equities
US0124231095
Biotechnology & Medical Research
Managers
Managers | Title | Age | Since |
---|---|---|---|
Philip W Macnabb
CEO | Chief Executive Officer | - | 30/04/23 |
Meera Khullar
CMP | Compliance Officer | - | 28/02/19 |
Prakash Pandian
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/18 |
Chief Tech/Sci/R&D Officer | - | 30/09/19 | |
Javier Gallo
PRN | Corporate Officer/Principal | - | - |
Scott Wagner
PRN | Corporate Officer/Principal | - | 31/12/18 |
Human Resources Officer | - | 30/09/17 | |
Stacie Phillips
LAW | General Counsel | 50 | 31/07/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Mihas
BRD | Director/Board Member | 57 | - |
Sean Cunningham
BRD | Director/Board Member | 48 | - |
William McMullan
BRD | Director/Board Member | 46 | - |
Maria Hilado
BRD | Director/Board Member | 59 | 31/08/21 |
Director/Board Member | 46 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 48,631,283 | 30,278,873 ( 62.26 %) | 5,512,000 ( 11.33 %) | 62.26 % |
Company contact information
![address Albany Molecular Research, Inc.](https://cdn.zonebourse.com/static/address/8359.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+17.72% | 44.44B | |
-10.33% | 37.99B | |
+37.55% | 37.75B | |
+29.36% | 30.78B | |
-8.44% | 27.38B | |
+12.45% | 26.17B | |
+44.19% | 14.15B | |
+31.93% | 12.59B | |
-7.67% | 11.28B |